NDC 0078-1077

VOTRIENT

Pazopanib Hydrochloride

VOTRIENT is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Pazopanib Hydrochloride.

• Product ID: 0078-1077_2b1d914b-1025-4401-b527-c15d4ca9fedc
• NDC: 0078-1077
• Product Type: Human Prescription Drug
• Proprietary Name: VOTRIENT
• Generic Name: Pazopanib Hydrochloride
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2016-07-12
• Marketing Category: NDA /
• Application Number: NDA022465
• Labeler Name: Novartis Pharmaceuticals Corporation
• Substance Name: PAZOPANIB HYDROCHLORIDE
• Active Ingredient Strength: 200 mg/1
• Pharm Classes: Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0078-1077-66

120 TABLET, FILM COATED in 1 BOTTLE (0078-1077-66)

• Marketing Start Date: 2021-12-13
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "VOTRIENT" or generic name "Pazopanib Hydrochloride"

NDC	Brand Name	Generic Name
0078-0670	VOTRIENT	pazopanib hydrochloride
0078-1077	VOTRIENT	pazopanib hydrochloride